[Amyotrophic lateral sclerosis (ALS): current perspectives and the Swiss ALS Registry]

Area of Science:

• Neuroscience
• Genetics
• Epidemiology

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive muscle weakness.
• While genetic mutations are implicated, environmental and lifestyle factors also contribute to ALS risk.
• Current treatments offer limited efficacy, and diagnosis is often delayed.

Purpose of the Study:

• To establish the Swiss ALS Registry for comprehensive data collection.
• To enhance understanding of ALS risk factors, disease progression, and therapeutic strategies.
• To facilitate research into genetically determined forms of ALS and potential genetic therapies.

Main Methods:

• The Swiss ALS Registry collects extensive data on environmental exposures, lifestyle choices, clinical presentations, genetic profiles, and biomarkers.
• Data collection aims to provide a holistic view of factors influencing ALS.
• Utilizes clinical evaluation, electroneuromyography, imaging, and molecular genetic testing.

Main Results:

• The registry is actively collecting diverse data crucial for ALS research.
• Established a foundation for analyzing risk, progression, and treatment efficacy.
• Identified key areas for future research in personalized and genetic therapies.

Conclusions:

• Comprehensive data registries are vital for advancing ALS research.
• Understanding multifactorial ALS risk is key to developing effective interventions.
• The Swiss ALS Registry will contribute to improved patient outcomes and therapeutic development.